摘要
目的:了解产超广谱β-内酰胺酶(ESBLs)大肠埃希菌的耐药性,为临床合理选用抗生素提供依据。方法:2005年9月~2006年6月,收集临床分离产ESBLs大肠埃希菌63株,采用琼脂平皿稀释法进行MIC测定。结果:产ESBLs大肠埃希菌对碳青霉烯类和哌拉西林/他唑巴坦普遍敏感,对哌拉西林和喹诺酮类耐药率分别为98.41%和90.48%,对头孢吡肟、头孢哌酮/舒巴坦、头孢他啶、头孢西丁、头孢噻肟和头孢曲松耐药率依次为34.92%、36.51%、44.45%、55.56%、82.54%和84.13%。结论:我院产ESBLs大肠埃希菌耐药明显。
Objective : To study the resistance of the extended-spectrum β-lactamases ( ESBLs ) -producing Escherichia coli ( E. coli) strains and to provide basis for clinical therapy, nethods:Agar dilution method was used to determine MICs of 13 antibiotics against 63 strains of ESBLs-producing E. coli which were collected between October 2005 and June 2006 in our hospital. Results: ESBLsproducing E. coli was generally sensitive to carbopenems and piperacillin/tazobatan, while most strains were highly resistant to piperacillin and quinolones. The rate of resistance to cefepime, ceforazone/sulbactam, ceftazidime, cefoxitin, ceftaxime and ceftriaxone were 34.92% ,36.51%, 44.45 %, 55.56% , 82.54% and 84. 13%, respectively. Conclusions : ESBLs-producing E. coil strains are highly resistant to antibiotics in our hospital.
出处
《蚌埠医学院学报》
CAS
2008年第5期531-532,共2页
Journal of Bengbu Medical College